TNF and neoplasm: Notably, no significant haemorrhage occurred in the liver, kidney, and spleen (Supplementary Fig. 4) because Vadimezan specifically targets tumour endothelial cells and induces tumour necrosis factor-α (TNF-α) secretion, which is known to cause haemorrhagic necrosis in tumours22.